Our staff remains available to you 24/7, offering safe and contactless client services by phone, email and video conference. Learn More!

Some Consolidated Transvaginal Mesh Lawsuits May Reach Settlement

This content is for informational purposes only Trantolo & Trantolo is not currently accepting cases for this lawsuit. Please check in the future for any updates.   Are the thousands of cases concerning multiple manufacturers’ transvaginal mesh devices close to reaching a settlement? An October 15 report reveals that Endo Health Solutions is considering it….

Read More

Verdicts Reached in First Two Consolidated Transvaginal Mesh Lawsuits

This content is for informational purposes only Trantolo & Trantolo is not currently accepting cases for this lawsuit. Please check in the future for any updates.   Six manufacturers of transvaginal mesh products are facing 23,000 lawsuits, all of which have been consolidated and are being tried in the U.S. District Court, Southern District of…

Read More

Consumer Safety Website Recommends Blood Test to Determine Hip Replacement Failure

For the thousands made aware of the risks associated with hip implants by the latest recall, the question of “How do I know my hip replacement is defective?” frequently comes up. As a study revealed 12 percent of all DePuy implant recipients required revision, or corrective, surgery within a five-year window, finding out if the…

Read More

Number of Transvaginal Mesh Lawsuits Continues to Grow

This content is for informational purposes only Trantolo & Trantolo is not currently accepting cases for this lawsuit. Please check in the future for any updates.   Announced in the Boston Business Journal this week, the number of lawsuits against Boston Scientific Corporation, one of six transvaginal mesh manufacturers, has been increasing. This growth, which…

Read More

Depakote Manufacturer Facing New Consolidated Lawsuit Related to Marketing Practices

Over the past few years, Abbott Laboratories has faced multiple lawsuits concerning Depakote, an anti-seizure medication approved by the FDA in 1983. Now, according to a report from Bloomberg, another lawsuit is directed toward the drug manufacturer – this time from Abbott’s shareholders. Although initially rejected last year, the lawsuit accuses Abbott’s directors of avoiding…

Read More